Lydia Warburton
- Oncology top 10%
- Cancer Research top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Immunology
- Co-authors
- Elin S. GrayMichael MillwardLeslie CalapreMel ZimanTarek MeniawyMichelle R. PereiraAshleigh C. McEvoyMuhammad A. Khattak
- Topics
- Cancer Immunotherapy and Biomarkers (14 papers)Cancer Genomics and Diagnostics (12 papers)CAR-T cell therapy research (10 papers)
- Partner nations
- AustraliaGermanySaudi Arabia
In The Last Decade
Lydia Warburton
21 papers receiving 406 citations
Hit Papers
Peers
Comparison fields: 5 of 54
- Oncology 242
- Cancer Research 224
- Molecular Biology 199
- Pulmonary and Respiratory Medicine 93
- Immunology 60
Countries citing papers authored by Lydia Warburton
This map shows the geographic impact of Lydia Warburton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Warburton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Warburton more than expected).
Fields of papers citing papers by Lydia Warburton
This network shows the impact of papers produced by Lydia Warburton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Warburton. The network helps show where Lydia Warburton may publish in the future.
Co-authorship network of co-authors of Lydia Warburton
This figure shows the co-authorship network connecting the top 25 collaborators of Lydia Warburton. A scholar is included among the top collaborators of Lydia Warburton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lydia Warburton. Lydia Warburton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | A scoping review of factors influencing the implementation of liquid biopsy for cancer carebreakdown → | 16 |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 5 | |
| 8 | 1 | |
| 9 | 13 | |
| 10 | 3 | |
| 11 | 4 | |
| 12 | 17 | |
| 13 | 23 | |
| 14 | 16 | |
| 15 | 11 | |
| 16 | 16 | |
| 17 | 8 | |
| 18 | 82 | |
| 19 | 3 | |
| 20 | 17 |
About Lydia Warburton
Lydia Warburton is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 411 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Cancer Genomics and Diagnostics (12 papers) and CAR-T cell therapy research (10 papers). The work is most often cited by research in Cancer Research (224 citations), Oncology (242 citations) and Molecular Biology (199 citations). Lydia Warburton has collaborated with scholars based in Australia, Germany and Saudi Arabia. Frequent co-authors include Elin S. Gray, Michael Millward, Leslie Calapre, Mel Ziman, Tarek Meniawy, Michelle R. Pereira, Ashleigh C. McEvoy, Muhammad A. Khattak, Benhur Amanuel and Anna Reid. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.